Objective: Panic disorder (PD) is now recognized as a common and important problem in children, and particularly adolescents, and one that can negatively affect daily well-being and educational performance. The aim of this study was to investigate the relationship between heart rate variability (HRV) and the severity of symptoms before and after treatment with psychotherapy and fluoxetine. Methods: The PD study group consisted of 23 children diagnosed with PD and the healthy control (HC) group comprised 27 healthy children. Panic-anxiety symptoms were measured using 2 assessments performed before and after treatment. HRV was evaluated with a 24-hour Holter examination. Results: According to the analysis of the 24-hour, all-day Holter device recordings, the high frequency (HF) and parasympathetic (%) scores in the PD group were lower than those of the HC group (p<0.05). The low frequency (LF)/HF ratio and sympathetic (%) scores in the PD group were higher than those of the HC group (p<0.05). The analysis of daytime readings indicated that the HF values of the PD group were lower than those of the HC group (p<0.05), while the very LF/ HF ratio and LF/HF ratio were higher than those of the HC group (p<0.05). Analysis of nighttime Holter results revealed that the rMSSD, pNN50, and HF readings of the PD group were lower than those of the HC group (p<0.05), while the LF/ HF ratio in PD patients was higher than that seen in the HC group (p<0.05). Conclusion: In children and adolescents with PD, increased sympathetic activity can cause changes in some HRV parameters. Some of these changes may return to normal with treatment.
P anic disorder (PD) is a clinical and socioeconomic problem characterized by recurrent unexpected panic attacks chracterized by symptoms of autonomic arousal, hyperventilation, dizziness, tremor, chest discomfort, sweating, and hot/ cold flushes. [1] The lifetime prevalence has been reported to be about 4.7% in adults and 0.5% to 5% in children and adolescents. [2] Psychotherapy, especially cognitive behavioral therapy (CBT) and pharmacotherapy, particularly with selective serotonin reuptake inhibitors (SSRIs) is considered effective firstline treatment for patients with PD. But, only some 11% of adult patients with PD receive CBT or SSRI treatment, and the figure is not much higher in children. [3] [4] [5] An increased risk of cardiac events associated with PD has been linked to an abnormal or dysregulated autonomic system and alterations in heart rate variability (HRV) in adults. [6] [7] [8] [9] [10] HRV is a measurement of the beat-to-beat difference in heart rate. It is controlled by the activity of the autonomic nervous system and reflects the capacity for parasympathetic inhibition of autonomic arousal. HRV may be considered a noninvasive measurement of the activity of the sympathetic and parasympathetic nervous systems. Spectral analysis is the most commonly used method for HRV analysis. It provides information about 3 separate frequency bands: high frequency (HF), low frequency (LF), and very low frequency (VLF). The HF component of HRV reflects parasympathetic activity and the LF component reflects both sympathetic and parasympathetic activities. HRV indicates dominance of the sympathetic or parasympathetic system rather than the relationship between the 2 systems. [5] A normal HRV reflects a healthy autonomic nervous system response to changing circumstances. However, a decreased HRV is an expression of the impairment of this response and may be correlated with the severity of cardiac disorders, especially in young patients with ischemic heart diseases. [11] In recent years, there has been significant research about HRV abnormality without heart disease in various mental disorders, including depression, PD, eating disorders, and schizophrenia in adult patients, [12] [13] [14] [15] but to our knowledge, no study to date has examined treatment effectiveness and HRV using all-day, daytime, nighttime parameters with 24-hour Holter monitoring in children and adolescents with mental disorders, particularly those with PD.
The objective of this study was to evaluate whether HRV was associated with the severity of PD symptoms in children and adolescents.
METHODS

Participants and procedures
The PD group consisted of 23 children and adolescents, and a healthy control (HC) group was made up of 27 healthy children and adolescents. PD was diagnosed based on clinical criteria and the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Patients with PD had no additional psychopathology. The Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime version assessment was not used in the diagnostic phase.
The research protocol was approved by the Research Ethics Board of Kahramanmaras Sutcu Imam University. Participants in the study group were recruited from newly diagnosed children with PD who were referred to the Necip Fazıl City Hospital Child and Adolescent Psychiatry between January and June 2015. The aim and procedures of the study were explained to all of the children and their parents, and written informed consent was obtained. The members of the PD group were aged between 7 and 16 years. The healthy, age and gender-matched control group was aged between 8 and 17 years.
A physical examination, hemogram, thyroid function tests, electrocardiography, and transthoracic 
Measurement of severity of anxiety level in panic disorder group
The psychopathological burden and severity of panicanxiety symptoms were evaluated before and after 6 to 8 weeks of CBT and SSRI (fluoxetine) treatment. Two assessment tools were used: the Beck Anxiety Inventory (BAI), which is a 21-item, self-report instrument to measure the severity of anxiety, and the State-Trait Anxiety Inventory (STAI), which is a commonly used 4-point scale that consists of 20 items to assess trait anxiety and 20 items to evaluate state anxiety. [16, 17] 
Treatment
At the outset of this longitudinal study, all of the children were treated with both CBT and fluoxetine. The CBT was conducted by a child and adolescent psychiatrist in weekly sessions lasting 45 minutes for 6 to 8 weeks. The types of CBT used included psychoeducation, breathing retraining, progressive muscle relaxation, cognitive restructuring, interceptive exposure, and situational exposure. [18] Fluoxetine was administered at 20 mg daily for the first 2 weeks and increased to 40 mg daily if the response was determined to be inadequate.
Evaluation of heart rate variability
HRV was assessed using time domain and frequency domain analysis with a 24-hour Holter device examination of the PD patients recorded before and after treatment and in the healthy group. To evaluate the HRV in this study, the following time domain parameters were used: mean heart rate (HR), the mean RR interval, the standard deviation of all normal sinus RR intervals over a 24-hour period (SDNN), the mean of the SDNN (SDNN index), the mean of the standard deviation of all averaged normal sinus intervals for each 5-minute segment in the 24-hour recording (SDANN index), the root mean square of successive differences between normal sinus NN intervals (rMSSD), and the percentage of successive NN intervals greater than 50 milliseconds (pNN50). In addition, the following frequency domain parameters were used: the total spectral power, very low frequency (VLF; 0.0033-0.04 Hz), low frequency (LF; 0.04-0.15 Hz), high frequency (HF; 0.15-0.40 Hz), VLF/HF ratio, LF/HF ratio, sympathetic activity (%), parasympathetic activity (%), and sympathetic activity/parasempathetic activity ratio. [13] [14] [15] 
Statistical analysis
The study data were analyzed with the IBM SPSS Statistics for Windows, Version 22.0 (IBM Corp., Armonk, NY, USA) statistical software package. The normality of the distribution of numeric variables was tested using the Shapiro-Wilk test and Q-Q graphics. Statistical comparisons between the patient and control groups were conducted with an independent samples t-test for variables with normal distribution and the Mann-Whitney U test for the data that did not follow a normal distribution. The correlation between anxiety scale score and HRV parameters was examined using Spearman's correlation analysis. Comparison of repeated measurements was conducted with a paired sample t-test or the Wilcoxon test. A value of p<0.05 was considered statistically significant.
RESULTS
The PD patients were aged between 7 and 16 years (mean: 13.1±2.8 years). The HC group was aged between 8 and 17 years (mean: 13.2±2.1 years). There were no significant differences between the groups According to the daytime HRV analyses, the HF scores of PD patients were significantly lower than those of the HC group (p<0.05), while the VLF/HF ratio and LF/HF ratio in PD patients were higher than those of the HC group (p<0.05). After treatment, there was a statistically significant decrease in the LF/HF ratio (p<0.01) ( Table 3 ).
The nighttime analyses indicated that the rMSSD, pNN50, and HF of the PD group were significantly lower than those of the HC group (p<0.05), while the LF/HF ratio in the PD patients was higher than those recorded in HC subjects (p<0.05). After treatment, there was a statistically significant increase in rMSSD and pNN50 (p<0.01) ( Table 4 ).
Correlation between anxiety scale score and heart rate variability parameters
Prior to treatment, the BAI of the PD patients demonstrated significant negative correlations with the in terms of gender, age, weight, height, or body mass index.
The members of the PD group had significantly higher BAI, STAI-S, and STAI-T scores when compared with the control group (p<0.01) ( Table 1) . All of the anxiety scale scores decreased after treatment (p<0.01).
Change in heart rate variability parameters in panic disorder patients
The HRV parameters for all-day, daytime, and nighttime were measured. The 24-hour, all-day analyses of HF and parasympathetic (%) scores in the PD group were significantly lower than those of the HC group (p<0.05). The LF/HF ratio and sympathetic (%) scores in the PD group were higher than those of the HC group (p<0.05). After treatment, there was a statistically significant decrease in the LF/HF ratio (p<0.01) ( Table 2 ). all-day rMSSD, all-day pNN50, daytime rMSSD, daytime pNN50, and nighttime HF (p<0.05), and a significant positive correlation with the all-day LF/ HF ratio (p<0.05). After the treatment, the BAI score of the panic attack patients revealed negative correlations with the all-day rMSSD, all-day pNN50, nighttime rMSSD, nighttime pNN50, and nighttime HF (p<0.05). There was no correlation between other anxiety scores and HRV parameters ( Table 5 ).
DISCUSSION
The use of 24-hour Holter monitoring in children with panic disorder revealed that the all-day sympathetic tive effect on the daily state of well-being, PD should be treated with CBT and/or pharmacotherapy. [5] According to a meta-analysis published by Chalmers et al., [22] a decrease in HRV was associated with reduced pNN50, rMMSD, and HF values with an increased LF/HF ratio in patients diagnosed with anxiety disorders. [22] Our results were similar to those reported in the literature demonstrating a decrease in rMSSD and pNN50 at night, increased LF/HF ratios over the 24-hour monitoring period, as well as during the day and night, and decreased HF values seen in the all-day, daytime and nighttime measurements in children with PD. Our research revealed no published study evaluating the relationship between childhood PD and HRV using 24-hour Holter monitoring.
Our results indicated no significant difference between daytime and all-day rMSSD and pNN50 values. The nighttime rMSSD and pNN50 values were statistically significantly lower in the PD group. This sensitivity may be an important indicator of impaired sleep quality in PD.
The BAI correlated negatively with rMSSD, pNN50 and nighttime HF and positively with the LF/ HF ratio. We think that these parameters may be more sensitive in PD than other HRV parameters. In our study, some HRV parameters improved after CBT and fluoxetine treatment in children with PD.
In children and adolscents with PD, increased sympathetic activity can cause changes in some HRV parameters. Some of these changes may return to normal with treatment. activity and LF/HF ratio were elevated, parasympathetic activity and HF were decreased and there was a reduction in LF/HF ratio with treatment. Daytime HF was reduced, while the VLF/HF ratio and LF/HF ratio were increased, and there was a reduction in LF/ HF ratio with treatment. Nighttime rMSSD, pNN50, and HF values were reduced, while the LF/HF ratio was increased, and there were rMSSD, and pNN50 were increased with treatment. We found a correlation between the BAI anxiety scale and some HRV parameters. These results implied that in children with PD, increased sympathetic activity leads to a decrease in HRV. Not all, but some of the HRV parameters, returned to normal with treatment.
There are many studies indicating that psychiatric disorders like major depression, anxiety disorders, and post-traumatic stress syndrome can lead to a reduction in HRV in adults. [19] Furthermore, a number of studies have provided evidence of increased susceptibility to ventricular fibrillation, ventricular tachycardia, and sudden cardiac death among patients with coronary artery disease and depression. [20] In children, PD usually starts after puberty, and it is more common among girls. The most common physical symptoms are palpitations, chest pain, light-headedness, and shivering. Lipsitz et al. [21] found that psychiatric disorders were prevalent among young people referred to pediatric cardiologists for evaluation of chest pain. Psychological symptoms, such as a fear of dying or losing self-control, may be present. Patients with PD are at increased risk of comorbid psychiatric disorders and suicide attempts. As it can have a nega- 
Limitations
This study was conducted with a relatively small sample population. CBT and pharmacotherapy were not separately compared; hence, no evidence was obtained that could determine which treatment was more effective. Also, the absence of a 24-hour Holter follow-up examination in the control group is another limitation of this study.
Conclusion
In children with PD, increased sympathetic activity causes changes in some HRV parameters. Some of these changes that create a decrease in HRV may return to normal with treatment. We think that such HRV data and the different effects seen during the day and at night may provide valuable information in the diagnosis of PD and its response to treatment.
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